Denovo (software)

Denovo (software). Denovo is an open-source software platform designed for advanced molecular simulation and computational chemistry research. Developed by an international consortium of academic researchers, it provides a suite of tools for modeling complex chemical systems and biomolecular interactions. The software is widely utilized in fields such as drug discovery, materials science, and biochemistry to predict molecular behavior and properties.

Overview

Denovo integrates multiple simulation methodologies, including molecular dynamics, quantum mechanics, and coarse-grained modeling, into a unified computational framework. Its architecture is built to leverage high-performance computing environments, such as those utilizing GPUs and MPI protocols on supercomputer clusters. The platform is maintained by the Denovo Research Group, a collaboration primarily involving scientists from Stanford University, the Max Planck Institute, and the University of Cambridge. Its development is supported by grants from institutions like the National Science Foundation and the European Research Council.

Features

A core feature of Denovo is its modular plugin architecture, which allows researchers to extend its capabilities with custom algorithms and force fields. It includes advanced sampling techniques, such as replica-exchange molecular dynamics and metadynamics, for exploring complex energy landscapes. The software offers robust tools for free energy calculation, crucial for applications in rational drug design and protein-ligand binding studies. Visualization and analysis modules are integrated with popular tools like VMD and PyMOL, and it supports standard file formats including PDB and TRR.

Development and history

The Denovo project was initiated in 2015 by a team of computational chemists at Stanford University led by Dr. Eleanor Vance, responding to a need for more adaptable and scalable simulation software. The first public release, version 1.0, was launched in January 2018 following a testing phase at the Lawrence Berkeley National Laboratory. Major version 2.0, released in 2020, introduced a rewritten core for GPU acceleration and support for machine learning-based potentials. Ongoing development is guided by a steering committee with representatives from partner institutions like the Massachusetts Institute of Technology and the Fritz Haber Institute of the Max Planck Society.

Applications

Denovo is extensively applied in pharmaceutical research for virtual screening and predicting the pharmacokinetics of novel drug candidates, with notable use by companies such as Pfizer and GlaxoSmithKline. In materials science, it aids in the design of new polymers, nanomaterials, and catalysts, with research published in journals like Nature Materials and Science. Academic groups employ it to study fundamental biochemical processes, such as enzyme catalysis and membrane protein dynamics, contributing to projects like the Human Proteome Project.

Technical details

The software is primarily written in C++ for computational efficiency, with user interfaces and scripting APIs provided in Python. It employs the OpenMM library for GPU-accelerated molecular dynamics and interfaces with quantum chemistry packages like Gaussian and ORCA for QM/MM simulations. Denovo runs on major operating systems including Linux, macOS, and Microsoft Windows, and its parallel computing capabilities are optimized for architectures from Cray and IBM. The codebase is hosted on GitHub and distributed under the GPLv3 license.

Category:Computational chemistry software Category:Free science software Category:Molecular modelling software